---
layout: post
title: "Changes to Third-Party Vendors for Risk Evaluation and Mitigation Strategies; Establishment of a Public Docket; Request for Comments"
date: 2026-02-05 18:35:59 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-05962
original_published: 2023-03-23 00:00:00 +0000
significance: 8.00
---

# Changes to Third-Party Vendors for Risk Evaluation and Mitigation Strategies; Establishment of a Public Docket; Request for Comments

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** March 23, 2023 00:00 UTC
**Document Number:** 2023-05962

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing the establishment of a docket to solicit comments on factors that generally should be considered by the Secretary of Health and Human Services (Secretary) when reviewing modification requests from sponsors of drugs subject to risk evaluation and mitigation strategies (REMS) related to changes in third-party vendors engaged by sponsors to aid in implementation and management of the strategies.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/03/23/2023-05962/changes-to-third-party-vendors-for-risk-evaluation-and-mitigation-strategies-establishment-of-a)
- API: https://www.federalregister.gov/api/v1/documents/2023-05962

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
